Vice President, MEG Oncology Head, Cross-Portfolio Excellence & MEG Alliances
Core
Own the 3-year strategic plan for the Oncology MEG portfolio (solid tumor and hematology), setting direction, priorities, and trade-offs for the full book of work including medical affairs, clinical research collaborations, and real-world evidence studies.
Role type
Senior IC Vice President, Medical Evidence Generation (MEG) Strategy
Builds
Strategic evidence generation plans, portfolio governance frameworks, and enterprise-level impact for oncology assets
Domain
Life Sciences / Oncology / Medical Evidence Generation
Required skills
Strategic portfolio leadership, Integrated evidence planning, Enterprise portfolio ownership, Matrix and executive leadership, Innovation and data-driven strategy, Portfolio governance and oversight, Organizational leadership, External and executive engagement
Preferred skills
Specialization in solid tumor and/or hematology, Cross-functional alignment and influence, Outcome-driven execution, People management excellence, Entrepreneurial mindset, Strong executive presence
Technologies
Digital and AI tools, data analytics
Responsibilities
Set strategic direction and priorities for the Oncology MEG portfolio, Provide executive oversight of Integrated Evidence Plans (IEPs), Lead and develop a team of 25+ professionals, Chair review committees for protocols and budgets, Serve as senior subject matter expert to senior leadership, Engage with external stakeholders and investigators
Seniority
Executive (VP), hands-on IC with organizational leadership